Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$683K Sell
6,017
-10,268
-63% -$1.22M ﹤0.01% 2131
2024
Q2
$2.02M Buy
+16,285
New +$2.1M 0.01% 1368
2024
Q1
Sell
-5,479
Closed -$675K 4490
2023
Q4
$597K Sell
5,479
-6,440
-54% -$668K ﹤0.01% 2488
2023
Q3
$1.23M Buy
11,919
+11,158
+1,466% +$1.2M 0.01% 1670
2023
Q2
$87.8K Buy
+761
New +$86.4K ﹤0.01% 3279
2023
Q1
Sell
-5
Closed -$540 4722
2022
Q4
$513 Buy
+5
New +$511 ﹤0.01% 4307
2022
Q3
Sell
-761
Closed -$67.9K 5680
2022
Q2
$87.8K Sell
761
-1,492
-66% -$132K ﹤0.01% 5317
2022
Q1
$185K Buy
+2,253
New +$178K ﹤0.01% 3938
2021
Q4
Sell
-96,110
Closed -$7.66M 5552
2021
Q3
$7.22M Buy
96,110
+74,388
+342% +$5.66M 0.02% 907
2021
Q2
$1.7M Buy
21,722
+19,931
+1,113% +$1.48M ﹤0.01% 2061
2021
Q1
$132K Buy
+1,791
New +$132K ﹤0.01% 4159
2020
Q2
Sell
-21,733
Closed -$1.64M 4656
2020
Q1
$1.6M Buy
+21,733
New +$1.71M 0.01% 1192
2019
Q4
Sell
-5,768
Closed -$474K 3798
2019
Q3
$463K Buy
+5,768
New +$462K ﹤0.01% 2328
2019
Q1
Sell
-13,277
Closed -$993K 4349
2018
Q4
$968K Buy
+13,277
New +$937K 0.01% 1794

Other funds holding MRK

PEAK6 Investments's MRK Position: Q3 2024 in Review

PEAK6 Investments reduced its Merck (MRK) stake by 63% in Q3 2024, selling an estimated $1.22M and leaving 6,017 shares worth $683K. The position accounts for ﹤0.01% of the portfolio, ranked #2131.

PEAK6 Investments first reported a position in MRK in Q4 2018 and has held it in 14 quarters since. The position peaked at $7.22M in Q3 2021. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • PEAK6 Investments held 6,017 shares of Merck worth $683K as of Q3 2024.
  • PEAK6 Investments sold 10,268 Merck shares in Q3 2024, an estimated $1.22M.
  • Merck made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2131 holding.
  • PEAK6 Investments first reported a position in Merck in Q4 2018 and has held it in 14 quarters since.
  • PEAK6 Investments's Merck position peaked at $7.22M in Q3 2021.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.